Breed · Dog

Poodle: adverse event reports

FDA breed label "Poodle (unspecified)" · single-breed animals only

Read this first · FDA's caveat, in its words

An API dataset query result cannot be used to estimate the risk associated with the product or compare one drug or device product with another. When looking at the results, be aware that there is no certainty that the reported drug or device caused the adverse event. This dataset should not be the sole source of information for clinical decision-making or other assumptions about the safety or effectiveness of a product. The adverse event may have been related to an underlying disease, other drugs used at the same time or other non-drug related sources. FDA Center for Veterinary Medicine

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.

Not veterinary advice. This site lists what was reported to FDA. For an animal that is unwell, contact a veterinarian.

8,723reports, 1987–20260.9% of dog reports

182reports, 12 months to March 2026152 in the 12 months before

27.1%classed serious, as reportedall dogs: 38.3%

14.5%name spinosadall dogs: 5.8%

FDA's database holds 8,723 reports where the animal's breed is given as "Poodle (unspecified)", shown here as Poodle: 0.9% of reports about dogs. Reports on crossbred animals are left out of breed pages.

182 reports arrived in the 12 months to March 2026, up 20% from 152 in the 12 months before. A breed's count mostly mirrors how common the breed is; registration and ownership figures by breed are not public data, so no per-animal rate can be given.

By active ingredient, the drugs named most often are spinosad, milbemycin oxime + spinosad and carprofen. Spinosad is named in 14.5% of this breed's reports, a larger share than in reports about all dogs (5.8%).

The terms listed most often are vomiting (25.5%), depression (11.3%) and anorexia (8.7%). Vomiting appears in 25.5% of reports, a larger share than in all dog reports (19.7%). 27.1% of reports stating seriousness were classed as serious, against 38.3% for dogs overall.

Drugs named most often, by active ingredient

Active ingredients recorded for the drug	Reports	Share of Poodle reports	Share of all dog reports
Spinosad	1,268	14.5%	5.8%
Milbemycin Oxime + Spinosad	1,107	12.7%	13.1%
Carprofen	647	7.4%	4.8%
Selamectin	525	6%	3%
Ivermectin + Pyrantel Pamoate	503	5.8%	14.9%
Moxidectin	421	4.8%	5%
Milbemycin Oxime	373	4.3%	3%
Cyclosporine	265	3%	1.5%
Selegiline Hydrochloride	225	2.6%	0.4%
Lufenuron + Milbemycin Oxime	219	2.5%	2.7%
Pyrantel Pamoate + Sarolaner	219	2.5%	5.1%
Fluralaner	191	2.2%	6.7%
Meloxicam	150	1.7%	0.8%
Deracoxib	145	1.7%	1.1%
Ivermectin	130	1.5%	1.3%
Oclacitinib	119	1.4%	2.9%
Sarolaner	109	1.2%	1.7%
Insulin	98	1.1%	0.7%
Amoxicillin	95	1.1%	0.3%
Nitenpyram	94	1.1%	1.1%

Ordered by report count. Differences from the species column often come from body size (which drugs a breed is prescribed) and from how common the breed was in the years a drug sold most. FDA states that these data cannot be used to estimate risk or to compare one product with another. Brand and manufacturer names are masked by FDA in these records.

Signs listed in reports

share of Poodle reports listing the termall dog reports

Vomiting25.5%2,226
Depression[dull, quiet or withdrawn]11.3%987
Anorexia[not eating]8.7%760
Diarrhoea[diarrhea]8.7%759
Emesis[vomiting]7.9%692
Lack of efficacy (ectoparasite) - flea[the product did not have the expected effect: fleas]6.4%557
Lethargy[unusually tired or inactive]4.8%417
Death4.6%405
Convulsion[seizure]4.4%383
Elevated alanine aminotransferase (ALT)[a liver enzyme above the normal range]4.2%365
Accidental exposure[exposure that was not intended]3.5%306
Ataxia[unsteady, uncoordinated movement]3.5%306
Elevated serum alkaline phosphatase (SAP)[a liver and bone enzyme above the normal range]3.4%297
Lack of efficacy (endoparasite) - hookworm[the product did not have the expected effect: hookworms]3.3%289
Pruritus[itching]3.2%276
Lack of efficacy - NOS[the product did not have the expected effect]3%258
Elevated blood urea nitrogen (BUN)[a kidney value above the normal range]2.4%210
Death by euthanasia[the animal was euthanized]2.4%207
Trembling2.3%201
Ineffective, heartworm larvae[legacy FDA term: the product did not have the expected effect (heartworm larvae)]2.2%194
Polydipsia[drinking more than usual]2.1%179
Bloody diarrhoea[diarrhea with blood]2%178
Leucocytosis NOS[high white blood cell count]1.9%168
Fever1.9%165
Seizure NOS[seizure, type not specified]1.8%160

Age and weight

Age of the animal

Under 1 year9.8%859

1 to 3 years24.5%2,139

4 to 7 years23.6%2,062

8 to 11 years20.3%1,769

12 years and over17.2%1,498

Age not given4.5%396

Weight of the animal

Under 5 kg (11 lb)39.1%3,413

5 to 9.9 kg (11–22 lb)33%2,881

10 to 24.9 kg (22–55 lb)15.5%1,353

25 to 44.9 kg (55–99 lb)7.1%623

45 kg and over (99 lb+)0%3

Weight not given5.2%450

Coloured bar: Poodle reports. Grey bar: all dog reports.

Trend and outcomes

Reports by month FDA received them. The newest months are incomplete because FDA posts reports with a delay of three to six months.

Outcome recorded in the report

Recovered/Normal16.8%1,464

Recovered with Sequela1.4%124

Ongoing7.4%647

Died6.7%584

Euthanized0.5%43

Outcome Unknown7.9%686

Beside all dogs

Measure	Poodle	All dogs
Reports	8,723	985,675
Latest 12 months	182	53,292
Classed serious, of reports stating it	27.1%	38.3%
Death or euthanasia recorded, per 1,000 reports	71.8	55

Questions about Poodle reports

How many FDA adverse event reports involve Poodles?

8,723 reports through March 2026, 0.9% of reports about dogs; 182 in the latest 12 months.

Which drugs are named most often in Poodle reports?

By active ingredient: spinosad (1,268), milbemycin oxime + spinosad (1,107), carprofen (647), selamectin (525) and ivermectin + pyrantel pamoate (503). Brands are masked in the public data.

What signs are reported most for this breed?

vomiting (25.5%), depression (11.3%), anorexia (8.7%), diarrhoea (8.7%) and emesis (7.9%).

Is the Poodle more sensitive to certain drugs?

Report counts cannot answer that. They show what was reported, not what a drug did, and they are not adjusted for how many Poodle animals exist or were treated. Breed-related drug sensitivities that are established are described on FDA-approved labels; a veterinarian is the person to ask about an individual animal.

Why are crossbreds not included?

FDA records crossbred animals with one or more component breeds. Counting them under each component would double count, so breed pages use single-breed reports only. Crossbreds remain in the species totals.

How do I report a problem?

Call the drug company using the number on the label, or send Form FDA 1932a to FDA. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Animal & Veterinary adverse event bulk files released 28 Sep 2026, which hold reports FDA's Center for Veterinary Medicine received through 31 Mar 2026. openFDA masks brand and manufacturer names in these files, so drugs are counted by the active ingredients each record discloses and no figure is attributed to a brand, application or company. Ingredient names, and the separate reference lists of approved products, follow the FDA Green Book as of 1 Oct 2026. Breed names are FDA's labels rearranged into everyday order ("Poodle (unspecified)" becomes "Poodle"). No report text, lot numbers or reporter details are published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.